Filters
reset allOther countries
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
GBA - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 7 | 1 |
|
Carrier Screening Guidelines-Based Panel Ambry Genetics United States | 199 | 165 |
|
Invitae Gaucher Common Variants Test Invitae United States | 7 | 1 |
|
Invitae Hereditary Parkinson Disease and Parkinsonism Panel Invitae United States | 44 | 26 |
|
Invitae Cerebral Palsy Spectrum Disorders Panel Invitae United States | 638 | 419 |
|
Non-Immune Hydrops Fetalis Panel PreventionGenetics United States | 291 | 148 |
|
Lysosomal Storage Disorders Panel PreventionGenetics United States | 242 | 146 |
|
Gaucher disease, type II, 230900, Autosomal recessive (Gaucher disease) (MLPA) Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Gaucher disease, type II, 230900, Autosomal recessive (Gaucher disease) (Prenatal) (MLPA) Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Invitae Comprehensive Lysosomal Storage Disorders Panel Invitae United States | 87 | 57 |
|
Invitae Lysosomal Storage Disorders Newborn Screening Panel Invitae United States | 19 | 10 |
|
GBA gene deletion/duplication analysis Duzen Laboratories Duzen BBAGUAS Turkey | 5 | 1 |
|
GBA (Gaucher Disease) Deletion/Duplication Analysis MNG Laboratories (Medical Neurogenetics, LLC.) United States | 7 | 1 |
|
GeneDx United States | 156 | 91 |
|
Myriad Genetics, Inc. United States | 112 | 110 |
|
Beacon Ashkenazi Jewish Male Carrier Screening Panel Fulgent Genetics United States | 145 | 41 |
|
Comprehensive Metabolism NGS Panel Fulgent Genetics United States | 602 | 355 |
|
Fulgent Genetics United States | 175 | 60 |
|
Beacon Ashkenazi Jewish Female Carrier Screening Panel Fulgent Genetics United States | 148 | 42 |
|
Beacon Expanded Female Carrier Screening Plus Panel Fulgent Genetics United States | 716 | 335 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.